Effect of scopolamine with propofol on nausea and vomiting

Comparison of scopolamine with propofol on nausea and vomiting in cesarean section under spinal anesthesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201207049639N6

Enrollment

Registered

2021-10-27

Start date

2021-11-11

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting. Nausea and vomiting

Interventions

Intervention 1: Intervention group: 3 minutes after spinal, bolus dose of scopolamine 0.02 mg/kg is injected intravenously (Manufacturer: Sigmaaldrich). Intervention 2: Control group: 3 minutes after

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Consent to participate in the study Age between 18-45 years Cesarean elective surgery

Exclusion criteria

Exclusion criteria: Weight more than 90 kg Having heart disease Allergy to anesthetics Twin pregnancy Taking anti-nausea drugs Having diabetes

Design outcomes

Primary

Measure	Time frame
Nausea and vomiting. Timepoint: After regional anesthesia. Method of measurement: Observation.	—

Secondary

Measure	Time frame
APGAR. Timepoint: 1 and 5 minutes after birth. Method of measurement: APGAR score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hadi Hooshyar

Oroumia University of Medical Sciences

hooshyar.h@umsu.ac.ir+98 44 3198 8293

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026